We are live on
!
Find out more
DSM Capital Partners Portfolio holdings
AUM
$5.84B
Turnover
50%
1-Year Est. Return
22.63%
This Fund
S&P 500
This Quarter
Est. Return
+12.3%
1 Year Est. Return
+22.63%
3 Year Est. Return
+148.09%
5 Year Est. Return
+176.14%
10 Year Est. Return
+916.71%
AUM
$6.74B
AUM Growth
+$615M
(+10%)
Cap. Flow
-$93.6M
Cap. Flow
% of AUM
-1.39%
Top 10 Holdings %
Top 10 Hldgs %
62.01%
Holding
48
New
9
Increased
14
Reduced
16
Closed
9
Avg Time Held
1.5
years
Top 10 Avg Time Held
1.5
years
Top 20 Avg Time Held
1.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$207M |
| 2 |
Microsoft
MSFT
|
+$188M |
| 3 |
COL
Rockwell Collins
COL
|
+$127M |
| 4 |
KSU
Kansas City Southern
KSU
|
+$119M |
| 5 |
Norwegian Cruise Line
NCLH
|
+$90M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$176M |
| 2 |
Affiliated Managers Group
AMG
|
+$139M |
| 3 |
Corpay
CPAY
|
+$117M |
| 4 |
Automatic Data Processing
ADP
|
+$105M |
| 5 |
AGN
Allergan plc
AGN
|
+$100M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 22.93% |
| 2 | Consumer Discretionary | 22.7% |
| 3 | Healthcare | 18.4% |
| 4 | Financials | 13.43% |
| 5 | Technology | 7.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
26
Wynn Resorts
WYNN
$7.93B
| $71.9M | 1.07% |
536,446
-303,026
| -36% | -$38.1M |
2017 Q1
1 quarter
|
|
27
Trip.com Group
TCOM
$25.2B
| $55.4M | 0.82% |
+1,028,880
| New | +$54.6M |
2017 Q2
0 quarters
|
|
28
Alphabet (Google) Class C
GOOG
$4.22T
| $46.3M | 0.69% |
1,018,180
-147,840
| -13% | -$6.77M |
2013 Q2
16 quarters
|
|
29
New Oriental
EDU
$9.35B
| $17M | 0.25% |
241,118
+60,678
| +34% | +$4.17M |
2017 Q1
1 quarter
|
|
30
Weibo
WB
$1.61B
| $16.6M | 0.25% |
+249,300
| New | +$16.2M |
2017 Q2
0 quarters
|
|
31
Intuitive Surgical
ISRG
$151B
| $12.1M | 0.18% |
116,226
-78,903
| -40% | -$7.58M |
2015 Q3
7 quarters
|
|
32
Autohome
ATHM
$2.34B
| $11M | 0.16% |
+243,110
| New | +$9.42M |
2017 Q2
0 quarters
|
|
33
Fomento Económico Mexicano
FMX
$41.3B
| $10.9M | 0.16% |
+111,223
| New | +$10.4M |
2017 Q2
0 quarters
|
|
34
Blackrock
BLK
$174B
| $3.18M | 0.05% |
7,533
+544
| +8% | +$217K |
2016 Q3
3 quarters
|
|
35
Lamar Advertising Co
LAMR
$15B
| $2.11M | 0.03% |
28,725
+3,250
| +13% | +$233K |
2015 Q3
7 quarters
|
|
36
iShares Russell 1000 Growth ETF
IWF
$127B
| $293K | ﹤0.01% |
9,852
-2,120
| -18% | -$62.2K |
2016 Q2
4 quarters
|
|
37
Coca-Cola Femsa
KOF
$24.3B
| $151K | ﹤0.01% |
+1,785
| New | +$139K |
2017 Q2
0 quarters
|
|
38
Dollar Tree
DLTR
$23.3B
| $6K | ﹤0.01% |
84
-1,139,992
| -100% | -$88M |
2016 Q2
4 quarters
|
|
|
39
Automatic Data Processing
ADP
$113B
| – | – |
-1,022,960
| Closed | -$105M | – |
|
|
40
Affiliated Managers Group
AMG
$9.9B
| – | – |
-844,974
| Closed | -$139M | – |
|
41
Invesco
IVZ
$12.7B
| – | – |
-24,000
| Closed | -$736K | – |
|
42
NXP Semiconductors
NXPI
$58.3B
| – | – |
-908,000
| Closed | -$94M | – |
|
43
Starbucks
SBUX
$110B
| – | – |
-1,557,881
| Closed | -$91M | – |
|
44
Synchrony
SYF
$24.1B
| – | – |
-24,600
| Closed | -$844K | – |
|
45
Vipshop
VIPS
$6.27B
| – | – |
-848,870
| Closed | -$11.3M | – |
|
|
46
Corpay
CPAY
$26.7B
| – | – |
-770,220
| Closed | -$117M | – |
|
|
CELG
47
DELISTED
Celgene Corp
CELG
| – | – |
-1,411,816
| Closed | -$176M | – |
|
Similar funds
KCM
JWCA
DSM Capital Partners's Q2 2017 Portfolio in Review
As of Q2 2017, DSM Capital Partners held 48 positions worth $6.74B, up 10% from $6.13B the previous quarter. Its ten largest holdings account for 62% of the portfolio.
DSM Capital Partners's Q2 2017 filing shows 9 new, 14 increased, 16 reduced and 9 closed positions. Its largest new stake was Microsoft: 2,743,510 shares worth $189M. The largest sale was Celgene Corp, an estimated $176M.
By sector, the portfolio is most concentrated in Communication Services at 23% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- DSM Capital Partners's largest Q2 2017 buy was Microsoft: 2,743,510 shares worth $189M.
- DSM Capital Partners added most to Regeneron Pharmaceuticals in Q2 2017, an estimated $207M increase.
- DSM Capital Partners's biggest Q2 2017 reduction was Allergan plc, cutting an estimated $100M.
- DSM Capital Partners fully exited Celgene Corp in Q2 2017, selling an estimated $176M.
- DSM Capital Partners's ten largest holdings make up 62% of its $6.74B portfolio in Q2 2017.
- DSM Capital Partners opened 9 new positions and closed 9 in Q2 2017.
- DSM Capital Partners's portfolio value rose 10% quarter-over-quarter to $6.74B.
Based on DSM Capital Partners's 13F filing for Q2 2017, filed 14 Aug 2017.